Lili Zhao

Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers.

Stephanie A. Kazane, Zhidong Wang, Yu J Cao, 2021, ACS synthetic biology.

T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice.

E. Noessner, F. Momburg, U. Protzer, 2021, Journal of hepatology.

A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy

Bo Zhang, Dong Liu, Shuhong Li, 2022, Theranostics.